Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Permitted use of Pharma in Focus

Pharma in Focus includes both free and protected content. Free content is available to all users. Protected content is only available to registered users.

Permitted Use of Pharma in Focus protected content

  1. Pharma in Focus protected content is for the personal use of registered users only. Registered users are those who have paid a subscription for access to protected content. Protected content is any content not made available free of charge on the Pharma in Focus site or via the Pharma in Focus News Alert email.

  2. Registered users may:

    a) Access Pharma in Focus material either from their workplace computer or at home or at a remote computer if away temporarily.

    b) Make one hard copy for personal use

    c) Use the 'email a friend' facility in keeping with condition 3(a) below

  1. Registered users may not:

    a) use the 'email a friend' facility to redistribute Pharma in Focus as a whole or in any quantity or frequency which amounts to any person having substantially the benefit of unrestricted access to Pharma in Focus without having paid a subscription or having a subscription paid on their behalf

    b) use their registered email address, or permit it to be used, to allow others gain access to Pharma in Focus

    c) redistribute Pharma in Focus material to anyone by any other means.

TOP | BACK

Approvals Action
Pfizer antibiotic sees first generic
Southern Cross has added the first copy of a Pfizer antibiotic to the ARTG in a week which saw a flurry of generic activity.
Pipeline Monitor
Lilly, Amgen rev up major drugs
Lilly's Taltz and Amgen's Repatha both won significant extensions from the FDA this week as the companies attempt to build blockbuster futures out of their pipelines.
Perspective
Big city moves not just about the view
Moves by pharma companies to leave suburban sites for slick new city offices is as much about how they want to be seen as it is about the scenery.